Résultats de recherche - Portail des modèles médicaux de données (portail MDM)

Palliative and Hospice Care Staff Satisfaction

- 15/03/2021 - 1 Formulaire, 6 Groupes Item, 27 Eléments de données, 2 Langues

Groupes Item: First meeting before start of therapy, start of therapy, symptoms and other issues, Information and time, Expertise and support, After patient death

https://www.hope-clara.de/ The HOPE Hospice and Palliative Care Recording standard documentation is used for documentation of palliative care and as an instrument for quality assurance in pallatiave wards, hospices and oncological wards as well as in ambulatory services and palliative teams.

Physician's Global Assessment

- 07/03/2018 - 1 Formulaire, 2 Groupes Item, 13 Eléments de données, 1 Langue

Groupes Item: Administration, Physician's Global Assessment

Access granted by Nicole Magnolo

GSK Study ID 100807 Fluticasone Propionate from SERETIDE™ (500/50) DISKUS™ and Budesonide from Symbicort (200/6) Turbuhaler in patients with severe Chronic Obstructive Pulmonary Disease. Subject Diary Card - Subject Diary Card

- 10/10/2017 - 1 Formulaire, 3 Groupes Item, 48 Eléments de données, 1 Langue

Groupes Item: Subject Diary Card, Subject Diary Card, Subject Diary Card Treatment Period 2

Randomised, open label, two period, crossover study to compare the steroid systemic exposure of Fluticasone Propionate (FP) from FP/Salmeterol (SALM) (500/50) DISKUS and Budesonide (BUD) from BUD/formoterol (FOR).(200/6) Turbuhaler in patients with severe Chronic Obstructive Pulmonary Disease. Primary objective:To compare the exposure of the inhaled steroid fluticasone propionate (FP) and budesonide following repeat dosing with SERETIDE DISKUS (500/50) one inhalation twice daily (b.i.d.) when compared with Symbicort Turbuhaler (200/6) two inhalations b.i.d. in a severe chronic pulmonary obstructive disease (COPD) population. Secondary objectives:To compare the pharmacokinetics of FP and budesonide following repeat dosing with SERETIDE DISKUS (500/50) one inhalation b.i.d. when compared with Symbicort Turbuhaler (200/6) two inhalations b.i.d. in a severe COPD population and to explore further the pharmacokinetics of FP and budesonide.

daily record card administration salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

- 16/08/2017 - 1 Formulaire, 2 Groupes Item, 7 Eléments de données, 1 Langue

Groupes Item: administrative data, next clinic visit

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

daily record card documentation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

- 16/08/2017 - 1 Formulaire, 4 Groupes Item, 19 Eléments de données, 1 Langue

Groupes Item: administrative data, documentation of health status, symptoms of COPD, worksheet

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

Documentation Psychosomatic medicine UKM - Documentation Form

- 25/03/2017 - 1 Formulaire, 5 Groupes Item, 24 Eléments de données, 2 Langues

Groupes Item: Patient demographics, Examination, Operationalised Psychodynamic Diagnostics (OPD), Pretreatment, Treatment

Documentation form converted to ODM format. Routine documentation of University Hospital of Münster. Publication granted by: Univ.-Prof. Dr. Dr.med. Gereon Heuft Klinik für Psychosomatik und Psychotherapie Universitätsklinikum Münster Domagkstr. 22 48149 Münster

University Hospital Essen nursing intervention daily verification

- 23/01/2017 - 1 Formulaire, 1 Groupe Item, 4 Eléments de données, 1 Langue

Groupe Item: Default Itemgroup

Hospital routine documentation models at the University Hospital Essen. Tables were derived from the Medico Information System. Original table name: n2017ppn

Skin Score chronic GvHD of skin NCT00000000 - Skin Score chronische GvHD der Haut NCT00000000

- 16/07/2016 - 1 Formulaire, 3 Groupes Item, 9 Eléments de données, 2 Langues

Groupes Item: Patient Data, Score Items, Investigator's Signature

F_Skin Score chronische GvHD der Haut_05042016 UKM Hautklinik Skin Score chronische GvHD der Haut [nach Greinix et al., 2007] Version: 1 Stand: 05.04.2016 Nächste Revision: 05.04.2018 Herausgeber: (Ihr Bereich) [X] Ärzte [_] Pflege [_] Verwaltung [_] Sonstige: Erstellt durch (Autoren): Geprüft durch: Freigegeben durch: Prof. Markus Böhm Henriette Kuithan Dr. Carsten Weishaupt Wichtiger Hinweis: Dieser Ausdruck ist eine unkontrollierte Kopie. Gültig ist nur die aktuelle Version in Nexus Curator.

Basic Documentation Melanoma - Metastasation diagnostics and diagnosis NCT00000000 - Basis Doku, Ausbreitungsdiagnostik und Diagnose, NCT00000000 Melanom Patientendokumentation

- 16/07/2016 - 1 Formulaire, 5 Groupes Item, 29 Eléments de données, 2 Langues

Groupes Item: Patient Data, propagation diagnosis: Lab, propagation diagnosis: Stage adapted, TNM Stage, Patient Data

Klinik und Poliklinik für Hautkrankheiten - Allgemeine Dermatologie und Venerologie - Direktor: Univ.-Prof. Dr. med. Th. A. Luger Melanom – Ausbreitungsdiagnostik und Diagnose DIN ISO Angaben: Version: 1 (Stand 30. Juli (Ersteller: Schiller/Hensen 07/08) (Prüfer: Weishaupt/Tsianakas 11/08) (Freigabe Sunderkötter 30. Juli 09) Melanom – Ausbreitungsdiagnostik und Diagnose

Basic Documentation Melanoma - secondary excision and follow up care NCT00000000 - Basisdokumentation Melanom – Nachexzision und regionäre Chirurgie NCT00000000

- 16/07/2016 - 1 Formulaire, 6 Groupes Item, 45 Eléments de données, 2 Langues

Groupes Item: Patient Data, Nachexzision, Clinical examination of regional Lymph nodes, SLND, Radical LAD, In-transit/Satellite-Metastases

Klinik und Poliklinik für Hautkrankheiten - Allgemeine Dermatologie und Venerologie - Direktor: Univ.-Prof. Dr. med. Th. A. Luger DIN ISO Angaben: Version: 1 (Stand 30. Juli 09 (Ersteller: Schiller/Hensen 07/08) (Prüfer: Weishaupt/Tsianakas 11/08) (Freigabe Sunderkötter 30.Juli 09) NCT00000000

Documentation of Course: Solid Tumors NCT00000000

- 27/06/2016 - 1 Formulaire, 6 Groupes Item, 32 Eléments de données, 2 Langues

Groupes Item: Visit Information, Basic Tumor Information, Medical history, Physical examination, List of Examinations, Other

Documentation of Course NCT00000000 Verlaufsbogen solide Tumoren Part

Baseline RICH study NCT02669589

- 12/06/2016 - 1 Formulaire, 21 Groupes Item, 234 Eléments de données, 1 Langue

Groupes Item: Patient Information, Patient Data, Kidney Disease: Improving Global Outcomes (KDIGO), Renal function, Neurologic dysfunction, Pulmonary dysfunction, Cardiovascular disorder, Gastrointestinal dysfunction, Other organ dysfunction, Main diagnosis for admission, Pre-existing illness, Premedication, Glasgow Coma Scale, Mechanical ventilation, Catecholamine and inotropic therapy, Vital signs, Concomitant medication, Laboratory Parameters and Blood Gas Analysis, Fluid balance, Transfusion, Microbiology

NCT02669589 EudraCT-Nr. 2014-004854 [Titel anhand dieser ISBN in Citavi-Projekt übernehmen] -33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

Mots-clés

Table des matières

Modèles de données sélectionnés